On the 11th of March 2020, the World Health Organization (WHO) declared COVID-19, caused by severe acute respiratory syndrome SARS CoV-2, a pandemic.
A new viewpoint article published in the journal JAMA Network in April 2020 deals with the use of a widely used category of cardiovascular medications in COVID-19 patients with hypertension, diabetes, and cardiovascular disease (CVD). These are the most common medical conditions that are found in COVID-19 patients and contribute disproportionately to mortality.
Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection.
Normal speech by individuals who are asymptomatic but infected with coronavirus may produce enough aerosolized particles to transmit the infection, according to aerosol scientists at the University of California, Davis.
Surgical masks may help prevent infected people from making others sick with seasonal viruses, including coronaviruses, according to new research that could help settle a fierce debate spanning clinical and cultural norms.
Scientists know that coronaviruses, including the SARS-CoV-19 virus responsible for the COVID-19 pandemic, can remain infectious for days -- or even longer -- in sewage and drinking water.
South Australian researchers working with Oracle Cloud technology and vaccine technology developed by local company Vaxine Pty Ltd are testing a vaccine candidate against the SARS-CoV-2 coronavirus responsible for the COVID-19 pandemic.
There are currently more than 10,000 scientific articles related to coronavirus infections. In fact, in recent weeks, research to combat COVID-19 has accelerated, and more than 4,000 new academic papers have been published on potential vaccines, therapies, and treatments.
A team of Spanish researchers have designed and validated a simulator to enable study of the evolution of the COVID-19 illness in Spain and in all Europe, based on parameters such as climate, social distancing policies and transportation.
A collaborative study led by Monash University's Biomedicine Discovery Institute in Melbourne, Australia, with the Peter Doherty Institute of Infection and Immunity, has shown that an anti-parasitic drug already available around the world kills the virus within 48 hours.
A team of UK biotech experts are close to delivering a sophisticated and affordable testing technology that will complement the simple binary COVID-19 tests currently in use.
COVID-19 has a significant impact on patients with pre-existing conditions, many of which fall under the cardiovascular and metabolic disorder category.
A Scotland-based virtual biobank dealing in ethically sourced human tissue samples is helping to speed up the provision of COVID-19 samples for researchers and drug developers working to find a cure for the global pandemic.